New eye implant shows promise for Long-Term wet AMD control

NCT ID NCT07516132

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This study is checking the long-term safety of an implant called OTX-TKI (axitinib) for people with wet age-related macular degeneration (AMD). The implant is placed in the eye and slowly releases medicine to control the disease. About 850 people who already completed two years of treatment in earlier studies will be followed for up to three more years. The main goal is to see if the implant remains safe over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
axitinib implant (OTX-TKI)
What this could lead to
If successful, this could show that the axitinib implant is safe for long-term use, potentially offering a treatment that reduces the need for frequent eye injections for wet AMD.
What could go wrong
This is an extension study focused on safety, not on how well the treatment works. It only includes people who already did well in earlier trials, so results may not apply to everyone with wet AMD.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Austin Retina Associates

    RECRUITING

    Austin, Texas, 78705, United States

  • California Retina Consultants (CRC)

    RECRUITING

    Bakersfield, California, 93309, United States

  • California Retina Consultants (CRC)

    RECRUITING

    Santa Barbara, California, 93103, United States

  • Cumberland Valley Retina Associates

    RECRUITING

    Hagerstown, Maryland, 21740, United States

  • Mid Atlantic Retina Specialists

    RECRUITING

    Hagerstown, Maryland, 21740, United States

  • Palmetto Retina Center

    RECRUITING

    West Columbia, South Carolina, 29619, United States

  • Retina Group of Florida - Fort Lauderdale

    RECRUITING

    Fort Lauderdale, Florida, 33308, United States

  • Retina Group of New England

    RECRUITING

    Waterford, Connecticut, 06385, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.